Enzo Biochem, Inc (NYSE:ENZ) has a beta value of 0.76 and has seen 1.73 million shares traded in the last trading session. The company, currently valued at $36.57M, closed the last trade at $0.70 per share which meant it lost -$0.31 on the day or -30.69% during that session. The ENZ stock price is -95.71% off its 52-week high price of $1.37 and -28.57% below the 52-week low of $0.90. If we look at the company’s 10-day average daily trading volume, we find that it stood at 95660.0 shares traded. The 3-month trading volume is 107.80K shares.
Enzo Biochem, Inc (NYSE:ENZ) trade information
Sporting -30.69% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ENZ stock price touched $0.70 or saw a rise of 33.96%. Year-to-date, Enzo Biochem, Inc shares have moved -44.80%, while the 5-day performance has seen it change -33.96%. Over the past 30 days, the shares of Enzo Biochem, Inc (NYSE:ENZ) have changed -32.69%. Short interest in the company has seen 0.42 million shares shorted with days to cover at 2.8.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Enzo Biochem, Inc (ENZ) estimates and forecasts
The company’s shares have lost -28.95% over the past 6 months.
ENZ Dividends
Enzo Biochem, Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.10 at a share yield of 14.29%. The company’s dividend yield has gone up over the past 12 months.
Enzo Biochem, Inc (NYSE:ENZ)’s Major holders
Insiders own 21.57% of the company shares, while shares held by institutions stand at 31.79% with a share float percentage of 40.53%. Investors are also buoyed by the number of investors in a company, with Enzo Biochem, Inc having a total of 53.0 institutions that hold shares in the company. The top two institutional holders are HARBERT FUND ADVISORS, INC. with over 5.18 million shares worth more than $5.64 million. As of 2024-06-30, HARBERT FUND ADVISORS, INC. held 10.1064% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 2.5 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.72 million and represent 4.8806% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 2.27% shares in the company for having 1.19 shares of worth $0.83 million while later fund manager owns 618.88 shares of worth $0.43 million as of Sep 30, 2024 , which makes it owner of about 1.18% of company’s outstanding stock.
